Free Trial

Galectin Therapeutics (GALT) SEC Filings & 10K Form

Galectin Therapeutics logo
$0.89 -0.15 (-14.41%)
(As of 12/23/2024 05:45 PM ET)

Recent Galectin Therapeutics SEC Filings

DateFilerForm TypeView
12/23/2024
3:17 PM
CALLICUTT JACK W (Reporting)
Galectin Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/23/2024
3:18 PM
Galectin Therapeutics (Subject)
LEWIS JOEL (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/23/2024
3:19 PM
Galectin Therapeutics (Subject)
Jamil Khurram (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/20/2024
6:50 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2024
7:03 AM
Galectin Therapeutics (Filer)
Form DEF 14A
12/03/2024
7:04 AM
Galectin Therapeutics (Filer)
Form DEFA14A
12/03/2024
7:05 AM
Galectin Therapeutics (Filer)
Form ARS
11/14/2024
6:55 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
7:00 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:51 AM
Galectin Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/23/2024
12:39 PM
ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
3:12 PM
FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:10 PM
Boudes Pol F (Reporting)
Galectin Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/09/2024
7:00 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2024
7:08 AM
Galectin Therapeutics (Issuer)
Zordani Richard A. Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
6:50 AM
Galectin Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2024
6:55 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2024
7:41 AM
Galectin Therapeutics (Issuer)
Jamil Khurram (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
7:38 AM
Galectin Therapeutics (Issuer)
Jamil Khurram (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/01/2024
6:50 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2024
8:43 AM
ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
Form 4/A
07/23/2024
8:38 AM
ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
12:55 PM
FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
6:50 AM
Galectin Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2024
6:55 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2024
1:14 PM
Galectin Therapeutics (Issuer)
Zordani Richard A. Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2024
12:27 PM
Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2024
10:37 AM
CZIRR JAMES C (Reporting)
Galectin Therapeutics (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
04/09/2024
3:42 PM
FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
6:51 AM
Galectin Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/29/2024
6:55 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
11:50 AM
Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
7:50 AM
CARSON BENJAMIN SR (Reporting)
Galectin Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/16/2024
10:23 AM
ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
7:07 AM
Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:GALT) was last updated on 12/24/2024 by MarketBeat.com Staff
From Our Partners